B

BridgeBio Oncology Therapeutics Inc
D

BBOT

12.140
USD
0.04
(0.33%)
مفتوح الان
حجم التداول
4,614
الربح لكل سهم
-55
العائد الربحي
-
P/E
-8
حجم السوق
971,062,660
المقالات

العنوان: BridgeBio Oncology Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.